JSI is providing global supply chain management expertise to support the Jadelle Access Program, Implanon Access Initiative, and the introduction of Sayana Press. Jadelle and Implanon are contraceptive implants that provide five and three years of protection, respectively, and Sayana Press is a three-month injectable depot medroxyprogesterone (DMPA) contraceptive product packaged in the Uniject™ injection system, a small prefilled auto-disable device.

Under a contract and grant with the Bill & Melinda Gates Foundation, JSI is supporting the programs in four ways:

JSI also reports to global advisory boards which monitor overall consumption of implants and work to ensure implants are being utilized in efforts to meet the FP 2020 goal of improving access to reproductive health commodities for 380 million women worldwide.